Molex Ventures

Molex Ventures is the corporate venture capital arm of Molex, the global electronic-connector and interconnect solutions manufacturer acquired by Koch Industries in 2013 for $7.2 billion. Established in 2013 and headquartered at Molex's corporate offices in Lisle, Illinois in the Chicago area, the vehicle connects startups with Molex's extensive design, engineering, and global manufacturing capabilities and the broader Koch Industries ecosystem. Molex Ventures focuses on four strategic themes aligned with Molex's core businesses: medical and pharmaceutical applications including sensors, connected health, and point-of-care diagnostics; automotive technology covering connected mobility, electrification, and autonomous driving; Industry 4.0 solutions spanning sensors, robotics, and data analytics platforms; and advanced electronics packaging technologies. The firm participates as a minority strategic co-investor rather than leading rounds, with checks typically between $1 million and $10 million. Across approximately eleven disclosed investments, notable portfolio companies include Point2 Tech ($23 million Series B), Credence MedSystems ($39.9 million round alongside Novartis Pharma), Windgap Medical (epinephrine autoinjector), and ECL, a California-based systems and information-management company that received its most recent investment in January 2023. Deal activity has slowed in recent years as Molex has shifted capital toward direct acquisitions, including Teramount for $430 million and Smiths Interconnect for £1.3 billion, rather than venture minority stakes. The vehicle remains available as a strategic entry point for startups seeking access to Molex's manufacturing relationships and Koch Industries' industrial portfolio.